TMEM158, as plasma cfRNA marker, promotes proliferation and doxorubicin resistance in ovarian cancer
The current study aimed to identify the potential biomarker for the diagnosis of ovarian cancer within plasma cell-free RNA (cfRNA) species and to …
Category: Diseases